News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ACC 2022 Can a Smartphone App Use Voice Patterns to Predict CAD Events? Caitlin E. Cox March 24, 2022
News Conference News ACC 2021 Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia Yael L. Maxwell May 16, 2021
News Conference News ACC 2020 A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA Michael O'Riordan March 28, 2020
News Conference News ACC 2020 More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA Michael O'Riordan March 28, 2020
News Conference News ACC 2018 Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Conference News ACC 2018 SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients Michael O'Riordan March 11, 2018
News Conference News ACC 2018 Thin Struts and ‘Pro-Healing’ Layer: COMBO Stent Sees Success at 1 Year Yael L. Maxwell March 11, 2018
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices L.A. McKeown April 03, 2016
News Conference News ACC 2013 SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI Caitlin E. Cox March 12, 2013
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013